世界中联老年医学专委会学术年会召开,马建中:发挥中医药防治老年疾病优势

2017-11-13 陈计智 中国中医

11月11日,以“优势互补、中医传承”为主题的世界中联老年医学专业委员会第六届学术年会暨2017北京中西医结合学会老年医学专业委员会学术年会在京召开。会议围绕世界老龄化、中医药抗衰老、医养结合养老模式建设,在中西医优势互补、中医药国际交流以及老年医学人才培养与基层医疗帮扶等方面进行了交流探讨。

11月11日,以“优势互补、中医传承”为主题的世界中联老年医学专业委员会第六届学术年会暨2017北京中西医结合学会老年医学专业委员会学术年会在京召开。会议围绕世界老龄化、中医药抗衰老、医养结合养老模式建设,在中西医优势互补、中医药国际交流以及老年医学人才培养与基层医疗帮扶等方面进行了交流探讨。

国家中医药管理局副局长、世界中医药学会联合会主席马建中出席会议并讲话。

国家中医药管理局副局长、世界中医药学会联合会主席马建中指出,世界中联老年医学专委会要进一步发挥好服务和团结广大老年专委会会员的桥梁纽带作用,不断增进世界范围内中医老年学术团体间交流合作。进一步发挥好学术交流平台作用,传承好发挥好中医药在老年疾病防治方面的特色优势,在不断丰富和完善中医老年疾病防治的方式方法、路径模式等方面加强交流、积极探索、形成经验。进一步发挥好与国际标准化组织的良好合作关系,推进中医药老年医学领域相关标准的制定发布工作。整合好自身优势,在推动中医老年医学相关服务贸易发展,助力中国“一带一路”倡议,推动中医药更好地造福人类健康等方面做出更大贡献。

会上,多位专家学者做专题报告。本次会议由世界中联老年医学专业委员会主办。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1669163, encodeId=20a816691636b, content=<a href='/topic/show?id=3ccb215e0b1' target=_blank style='color:#2F92EE;'>#中医药防治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21570, encryptionId=3ccb215e0b1, topicName=中医药防治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e7626506004, createdName=makuansheng, createdTime=Tue Mar 27 02:07:00 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1748393, encodeId=70241e4839364, content=<a href='/topic/show?id=a1e44554368' target=_blank style='color:#2F92EE;'>#学术年会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45543, encryptionId=a1e44554368, topicName=学术年会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=743c36117485, createdName=liuli5091, createdTime=Mon Apr 23 06:07:00 CST 2018, time=2018-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736986, encodeId=ff531e3698627, content=<a href='/topic/show?id=7b748019ef4' target=_blank style='color:#2F92EE;'>#老年疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80197, encryptionId=7b748019ef4, topicName=老年疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaca34235364, createdName=124984edm33暂无昵称, createdTime=Wed Apr 18 13:07:00 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261597, encodeId=292726159e00, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/04/7e2c04a7e58b6065a1392efd799c6a6b.jpg, createdBy=de482077642, createdName=王晓霞, createdTime=Thu Nov 16 02:54:42 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409174, encodeId=c46614091e420, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Nov 15 09:07:00 CST 2017, time=2017-11-15, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1669163, encodeId=20a816691636b, content=<a href='/topic/show?id=3ccb215e0b1' target=_blank style='color:#2F92EE;'>#中医药防治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21570, encryptionId=3ccb215e0b1, topicName=中医药防治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e7626506004, createdName=makuansheng, createdTime=Tue Mar 27 02:07:00 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1748393, encodeId=70241e4839364, content=<a href='/topic/show?id=a1e44554368' target=_blank style='color:#2F92EE;'>#学术年会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45543, encryptionId=a1e44554368, topicName=学术年会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=743c36117485, createdName=liuli5091, createdTime=Mon Apr 23 06:07:00 CST 2018, time=2018-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736986, encodeId=ff531e3698627, content=<a href='/topic/show?id=7b748019ef4' target=_blank style='color:#2F92EE;'>#老年疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80197, encryptionId=7b748019ef4, topicName=老年疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaca34235364, createdName=124984edm33暂无昵称, createdTime=Wed Apr 18 13:07:00 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261597, encodeId=292726159e00, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/04/7e2c04a7e58b6065a1392efd799c6a6b.jpg, createdBy=de482077642, createdName=王晓霞, createdTime=Thu Nov 16 02:54:42 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409174, encodeId=c46614091e420, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Nov 15 09:07:00 CST 2017, time=2017-11-15, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1669163, encodeId=20a816691636b, content=<a href='/topic/show?id=3ccb215e0b1' target=_blank style='color:#2F92EE;'>#中医药防治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21570, encryptionId=3ccb215e0b1, topicName=中医药防治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e7626506004, createdName=makuansheng, createdTime=Tue Mar 27 02:07:00 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1748393, encodeId=70241e4839364, content=<a href='/topic/show?id=a1e44554368' target=_blank style='color:#2F92EE;'>#学术年会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45543, encryptionId=a1e44554368, topicName=学术年会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=743c36117485, createdName=liuli5091, createdTime=Mon Apr 23 06:07:00 CST 2018, time=2018-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736986, encodeId=ff531e3698627, content=<a href='/topic/show?id=7b748019ef4' target=_blank style='color:#2F92EE;'>#老年疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80197, encryptionId=7b748019ef4, topicName=老年疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaca34235364, createdName=124984edm33暂无昵称, createdTime=Wed Apr 18 13:07:00 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261597, encodeId=292726159e00, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/04/7e2c04a7e58b6065a1392efd799c6a6b.jpg, createdBy=de482077642, createdName=王晓霞, createdTime=Thu Nov 16 02:54:42 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409174, encodeId=c46614091e420, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Nov 15 09:07:00 CST 2017, time=2017-11-15, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1669163, encodeId=20a816691636b, content=<a href='/topic/show?id=3ccb215e0b1' target=_blank style='color:#2F92EE;'>#中医药防治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21570, encryptionId=3ccb215e0b1, topicName=中医药防治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e7626506004, createdName=makuansheng, createdTime=Tue Mar 27 02:07:00 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1748393, encodeId=70241e4839364, content=<a href='/topic/show?id=a1e44554368' target=_blank style='color:#2F92EE;'>#学术年会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45543, encryptionId=a1e44554368, topicName=学术年会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=743c36117485, createdName=liuli5091, createdTime=Mon Apr 23 06:07:00 CST 2018, time=2018-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736986, encodeId=ff531e3698627, content=<a href='/topic/show?id=7b748019ef4' target=_blank style='color:#2F92EE;'>#老年疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80197, encryptionId=7b748019ef4, topicName=老年疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaca34235364, createdName=124984edm33暂无昵称, createdTime=Wed Apr 18 13:07:00 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261597, encodeId=292726159e00, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/04/7e2c04a7e58b6065a1392efd799c6a6b.jpg, createdBy=de482077642, createdName=王晓霞, createdTime=Thu Nov 16 02:54:42 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409174, encodeId=c46614091e420, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Nov 15 09:07:00 CST 2017, time=2017-11-15, status=1, ipAttribution=)]
    2017-11-16 王晓霞

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1669163, encodeId=20a816691636b, content=<a href='/topic/show?id=3ccb215e0b1' target=_blank style='color:#2F92EE;'>#中医药防治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21570, encryptionId=3ccb215e0b1, topicName=中医药防治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e7626506004, createdName=makuansheng, createdTime=Tue Mar 27 02:07:00 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1748393, encodeId=70241e4839364, content=<a href='/topic/show?id=a1e44554368' target=_blank style='color:#2F92EE;'>#学术年会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45543, encryptionId=a1e44554368, topicName=学术年会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=743c36117485, createdName=liuli5091, createdTime=Mon Apr 23 06:07:00 CST 2018, time=2018-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736986, encodeId=ff531e3698627, content=<a href='/topic/show?id=7b748019ef4' target=_blank style='color:#2F92EE;'>#老年疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80197, encryptionId=7b748019ef4, topicName=老年疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaca34235364, createdName=124984edm33暂无昵称, createdTime=Wed Apr 18 13:07:00 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261597, encodeId=292726159e00, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/04/7e2c04a7e58b6065a1392efd799c6a6b.jpg, createdBy=de482077642, createdName=王晓霞, createdTime=Thu Nov 16 02:54:42 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409174, encodeId=c46614091e420, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Nov 15 09:07:00 CST 2017, time=2017-11-15, status=1, ipAttribution=)]
    2017-11-15 cathymary